OTCM
SSREY
Market cap44bUSD
Jun 18, Last price
37.78USD
1D
-0.13%
1Q
-6.53%
Jan 2017
59.01%
IPO
159.70%
Name
Swiss Re AG
Chart & Performance
P/E
3.44
P/S
1.28
EPS
10.99
Div Yield, %
4.49%
Shrs. gr., 5y
-0.93%
Rev. gr., 5y
-29.28%
Revenues
8.73b
-82.46%
Net income
3.24b
+0.84%
CFO
3.13b
-23.40%
Dividend
Apr 16, 20241.7 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Zurich, Switzerland, in 1863, Swiss Re AG operates as a global entity providing an extensive range of risk management solutions. Its core business involves offering significant reinsurance capacity to other insurers, direct insurance offerings, and various alternative insurance-linked risk transfer mechanisms, along with associated support services, across the globe. The company's activities are structured into three main operating divisions: The Property & Casualty Reinsurance segment covers a broad array of risks. This includes property-related exposures such as credit and surety, engineering ventures, aviation, marine, agricultural policies, Sharia-compliant retakaful, and bespoke facultative reinsurance. It also addresses casualty risks, encompassing general liability, motor vehicle claims, workers' compensation, personal accidents, management and professional indemnity, cyber threats, and specific facultative arrangements. The Life & Health Reinsurance division is dedicated to underwriting and managing policies for life and health insurance. The Corporate Solutions segment delivers a diverse portfolio of risk transfer options, spanning from standard coverage and comprehensive multi-line programs to highly customized solutions designed for specific business needs. Swiss Re's client base is varied, serving established stock and mutual insurance companies, governmental and public sector bodies, mid-sized to large corporations, and private individuals alike.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||